SAB Biotherapeutics (SABS)
(Real Time Quote from BATS)
$4.25 USD
0.00 (0.00%)
Updated Apr 29, 2024 03:31 PM ET
After-Market: $4.25 0.00 (0.00%) 4:14 PM ET
4-Sell of 5 4
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/21/2024
Time: -- |
3/2024 | $-0.98 | 0.00% |
Earnings Summary
For their last quarter, SAB Biotherapeutics (SABS) reported earnings of -$1.00 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for SABS's next earnings release expected on May 21, 2024. For the next earning release, we expect the company to report earnings of -$0.98 per share, reflecting a year-over-year increase of 34.67%.
Earnings History
Price & Consensus
Zacks News for SABS
Adma Biologics (ADMA) Reports Q1 Loss, Tops Revenue Estimates
SABS: What are Zacks experts saying now?
Zacks Private Portfolio Services